Profound Medical Corp.
Profound Medical Corp.（PROF）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
prof · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$12.00
+82.6% upside
Low
$12.00
Median: $12 · Last Close: $6.57
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $6.41 | ↓ 2.37% |
1-day model range: $6.38–$6.45. Peak: $6.45 (-2.37%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -38.7% |
| 2028 | $3 | -50.6% |
| 2029 | $3 | -55.4% |
| 2030 | $3 | -57.6% |
| 2031 | — | -58.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PROF · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-01-07 | Lake Street | Maintains | Buy→Buy |
| 2025-04-23 | Lake Street | Maintains | Buy→Buy |
| 2024-07-16 | Stifel | Upgrade ↑ | Hold→Buy |
| 2024-03-11 | Alliance Global Partners | Maintains | Buy→Buy |
| 2024-03-08 | Stifel | Maintains | Hold→Hold |
| 2024-01-04 | Alliance Global Partners | Maintains | Buy→Buy |
| 2023-08-04 | Raymond James | Downgrade ↓ | Strong Buy→Outperform |
| 2023-05-11 | Alliance Global Partners | Maintains | Buy→Buy |
| 2023-05-11 | TD Cowen | Maintains | Outperform→Outperform |
| 2023-03-21 | Jefferies | Downgrade ↓ | Buy→Equal Weight |
Wall Street analysts have recently issued updated ratings on Profound Medical Corp. (PROF) stock. Of the recent 13 rating actions, 2 were upgrades and 3 were downgrades. 7 analysts currently cover PROF.
分析师推荐趋势
PROF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$26M
↓ 65.7% YoY
Revenue Next Year
$44M
↑ 69.3% YoY
EPS This Year
$-0.84
EPS Next Year
$-0.75
↓ 10.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast PROF EPS of $-0.84 for the current fiscal year, based on estimates from 4 analysts. The PROF revenue forecast is $26M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PROF 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PROF 的共识目标价为 $12.00（+82.6% 上行空间），分析师共识为 Buy。
PROF 的短期预测（明日）为 $6.41（-2.37%）。 PROF 对 2027 年的股价预测均值为 $4。 PROF 对 2030 年的预测区间为 $3–$3。
Profound Medical Corp. 在 NASDAQ 上市，代码 PROF。PROF 在 2027 年的整体展望偏积极，在覆盖分析师中约 86% 对应 Buy 共识。
常见问题
PROF 预测 · 8 个问题根据 7 位华尔街分析师，PROF 的 12 个月平均目标价为 $12.00，最高 $12.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $6.57，隐含约 +82.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.